# Reza Rezaei

> Reza Rezaei is the chief executive officer of Cyagen, a biotechnology research company that develops genetically engineered animal and cell models and provides preclinical research services. Trained as a veterinarian and animal scientist, he moved from research and teaching at Texas A&M into life-science sales, then rose through Cyagen's commercial organization from regional manager to sales director, vice president, and CEO. His career is a case study in translating technical fluency into customer relationships, product strategy, and company leadership.

- **Role:** Chief Executive Officer at Cyagen
- **Organizations:** Cyagen, Scientist Solutions, Texas A&M AgriLife Research, Texas A&M University, Boston University Questrom School of Business
- **Education:** Master of Business Administration (MBA), Boston University Questrom School of Business, Doctor of Philosophy (PhD), Animal Sciences / Nutritional Biochemistry, Texas A&M University, Master of Science (MS), Texas A&M University, Doctor of Veterinary Medicine (DVM)
- **Known for:** Advanced through four commercial and executive roles at Cyagen before becoming chief executive officer., Co-authored peer-reviewed research on amino-acid nutrition, animal growth and mammary biology, with papers indexed by PubMed., Combined veterinary training, animal-science research and commercial leadership in the preclinical research industry.

## Career timeline

- **2009-2014** — Worked as a research and teaching assistant at Texas A&M AgriLife while completing graduate study.
- **2013-2014** — Worked as a territory manager at Scientist Solutions, providing technical support and coordinating life-science events.
- **2014-2015** — Joined Cyagen as regional manager.
- **2015-2018** — Served as Cyagen's director of sales.
- **2018-2025** — Served as vice president of sales and business development at Cyagen, with responsibilities reported to include global sales planning, marketing and product development.
- **2025-present** — Became chief executive officer of Cyagen; the company's official leadership page currently lists him in the role.

## Achievements

- Advanced through four commercial and executive roles at Cyagen before becoming chief executive officer.
- Co-authored peer-reviewed research on amino-acid nutrition, animal growth and mammary biology, with papers indexed by PubMed.
- Combined veterinary training, animal-science research and commercial leadership in the preclinical research industry.
- Represented Cyagen at scientific meetings including AACR 2024, CIMT 2025 and ARVO 2026.
- Helped lead Cyagen's customer-facing work as the company expanded its model library and preclinical services partnerships.

## Latest updates

- **2026-05** — Represented Cyagen as chief executive officer at ARVO 2026 in Denver alongside the company's business development team.
- **2026-03** — Appeared in Cyagen's twentieth-anniversary team retrospective as chief executive officer.
- **2025-08** — Cyagen and Taconic announced a strategic distribution partnership covering more than 16,000 cKO/KO models and more than 200 Cre and reporter models.
- **2025-05** — Attended the CIMT 2025 Annual Meeting and discussed Cyagen's HUGO-Ab platform with Professor Jacob Hochman.
- **2025-03** — Helped welcome attendees to Cyagen's 2025 Global Partnership Forum in Taicang, China.

## Links

- Website: https://www.cyagen.com
- LinkedIn: https://www.linkedin.com/in/reza-rezaei-dvm-phd-mba-89b3a161/

---

Profile page: https://yespress.io/reza-rezaei
Published by YesPress — https://yespress.io
Last updated: 2026-08-18